Biomerica, Inc.

Equities

BMRA

US09061H3075

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 01:29:56 06/07/2024 am IST			5-day change	1st Jan Change
0.436 ^USD	-2.82%		-0.86%	-65.12%

01/07	Biomerica, Inc. Launches At-Home Sample Collection for inFoods IBS, Significantly Expanding Access for Millions of IBS Sufferers	CI
28/06	Biomerica, Inc. Announces Resignation of Jack Kenny as Board of Directors and All Committees Thereof and as the Chairman of the Board	CI

Biomerica : CE Mark COVID-19 Antigen Rapid Test

January 13, 2021 at 12:44 am IST

NEWS

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

Original document
Permalink

Disclaimer

Biomerica Inc. published this content on 12 January 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 January 2021 19:13:06 UTC

Latest news about Biomerica, Inc.

Biomerica, Inc. Launches At-Home Sample Collection for inFoods IBS, Significantly Expanding Access for Millions of IBS Sufferers	01/07	CI
Biomerica, Inc. Announces Resignation of Jack Kenny as Board of Directors and All Committees Thereof and as the Chairman of the Board	29/06	CI
Biomerica, Inc. Announces Infoods IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024	13/05	CI
Biomerica Enters Distribution Deal to Provide Home Screening Tests in UAE	29/04	MT
Biomerica and UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement	29/04	CI
Biomerica Provides Update on inFoods IBS Expansion	15/04	CI
Biomerica, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024	13/04	CI
Biomerica, Inc. Announces the Appointment of Gary Huff to Its Strategic Advisory Board	21/02	CI
Biomerica, Inc. Appoints Jack Kenny as Chairman of the Board of Directors	23/01	CI
Biomerica, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2023	16/01	CI
Top Premarket Decliners	19/12	MT
Biomerica Shares Rise After FDA 510(k) Clearance for H Pylori Bacteria Test	18/12	DJ
Biomerica, Inc. Receives US FDA 510(k) Clearance for their Hp Detect Stool Antigen ELISA Test Product Designed to Detect Presence of H. Pylori Bacteria	18/12	CI
Biomerica, Inc. Expands in Foods IBS Reach with Addition of Several New GI Groups	08/11	CI
Biomerica, Inc. Reports Earnings Results for the First Quarter Ended August 31, 2023	13/23/13	CI
Biomerica Says Dubai Approves Insurance Reimbursement for Colorectal Disease Screening Test	26/23/26	MT
Jack Kenny Joins Biomerica?S Board of Directors	28/23/28	CI
Biomerica, Inc. Reports Earnings Results for the Full Year Ended May 31, 2023	26/23/26	CI
Biomerica's Colorectal Disease Screening Test to be Available in CVS Stores in September	03/23/03	MT
Biomerica, Inc.(NasdaqCM:BMRA) dropped from Russell 3000E Index	23/23/23	CI
Biomerica, Inc.(NasdaqCM:BMRA) dropped from Russell Microcap Index	23/23/23	CI
Biomerica, Inc.(NasdaqCM:BMRA) dropped from Russell 3000E Growth Index	23/23/23	CI
Biomerica, Inc.(NasdaqCM:BMRA) dropped from Russell Microcap Growth Index	23/23/23	CI
Biomerica Inc. Receives Notice of Patent Allowance in China for A Potential Innovative Technology That Includes an Artificial Intelligence Claim for Predicting Foods That Contain Ingredients That Cause Adverse Reactions in Patients	21/23/21	CI
Certain Stock Options of Biomerica, Inc. are subject to a Lock-Up Agreement Ending on 1-JUN-2023.	01/23/01	CI

Chart Biomerica, Inc.

Duration

Period

More charts

Company Profile

Biomerica, Inc. is a biomedical technology company. The Company develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point-of-care (in home and in physiciansâ offices) and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. It is also engaged in the research, development, commercialization and in certain cases regulatory approval, of patented, diagnostic-guided therapy (DGT) products to treat gastrointestinal diseases, such as irritable bowel syndrome (IBS), and other inflammatory diseases. The Company's InFoods IBS product uses a simple blood sample and is designed to identify patient-specific foods that, when removed from the diet, may alleviate IBS symptoms such as pain, bloating, diarrhea and constipation. The Companyâs two subsidiaries, Biomerica de Mexico, which is used for assembly/manufacturing and BioEurope GmbH, which acts as a distributor of Biomerica products in certain markets.

Sector

Medical Equipment, Supplies & Distribution

Calendar

29/08/2024 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
BIOMERICA, INC.	-65.12%	7.33M
ABBOTT LABORATORIES	-5.50%	181B
MEDTRONIC PLC	-5.79%	99.52B
BECTON, DICKINSON AND COMPANY	-6.59%	65.82B
DEXCOM, INC.	-8.38%	45.21B
CENCORA, INC.	+8.42%	43.85B
HOYA CORPORATION	+10.10%	42.17B
METTLER-TOLEDO INTERNATIONAL, INC.	+10.97%	28.75B
TERUMO CORPORATION	+18.89%	25.39B
WEST PHARMACEUTICAL SERVICES, INC.	-8.39%	23.5B

Other Medical Equipment, Supplies & Distribution